Search results for "5-aminolevulinic acid"

showing 4 items of 4 documents

Safety of Novel Amino-5-laevulinate Photosensitizer Precursors in Photodynamic Therapy for Healthy Human Skin.

2015

Peer reviewed

0301 basic medicineAdultmedicine.medical_specialtyTime Factorsmedicine.medical_treatmenteducationPain5-AMINOLEVULINIC ACIDHuman skinPhotodynamic therapyPilot ProjectsEUROPEAN GUIDELINESDermatology030105 genetics & heredityAdministration Cutaneousphotodynamic therapy (PDT)ihosyöpä03 medical and health sciencesDouble-Blind MethodMedicineHumansPhotosensitizerProdrugsSkinACTINIC KERATOSESihoPhotosensitizing Agentsbusiness.industryGeneral MedicineActinic keratosesAminolevulinic AcidDermatologyHealthy Volunteers3. Good healthOikeuslääketiede ja muut lääketieteet - Forensic science and other medical sciencesREDUCES INFLAMMATIONPhotochemotherapyErythema3121 General medicine internal medicine and other clinical medicinebusinessActa dermato-venereologica
researchProduct

With a Little Help from My Friends: The Role of Intraoperative Fluorescent Dyes in the Surgical Management of High-Grade Gliomas

2018

High-grade gliomas (HGGs) are the most frequent primary malignant brain tumors in adults, which lead to death within two years of diagnosis. Maximal safe resection of malignant gliomas as the first step of multimodal therapy is an accepted goal in malignant glioma surgery. Gross total resection has an important role in improving overall survival (OS) and progression-free survival (PFS), but identification of tumor borders is particularly difficult in HGGS. For this reason, imaging adjuncts, such as 5-aminolevulinic acid (5-ALA) or fluorescein sodium (FS) have been proposed as superior strategies for better defining the limits of surgical resection for HGG. 5-aminolevulinic acid (5-ALA) is i…

Oncologymedicine.medical_specialtyReviewlcsh:RC321-571Resection03 medical and health scienceschemistry.chemical_compoundHigh-grade glioma0302 clinical medicineGliomaInternal medicineYELLOW 560 filterMedicinefluorescein sodiumastrocytomalcsh:Neurosciences. Biological psychiatry. NeuropsychiatryProtoporphyrin IXSettore MED/27 - Neurochirurgiabusiness.industryGeneral NeuroscienceglioblastomaAstrocytomaMultimodal therapymedicine.diseaseFluorescenceextent of resectionchemistry5-aminolevulinic acid030220 oncology & carcinogenesisPrimary Malignant Brain TumorsSodium fluoresceinbusinesshigh-grade gliomas030217 neurology & neurosurgeryBrain Sciences
researchProduct

Hexyl aminolevulinate, 5‐aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non‐aggressive basal cell carcinomas:…

2020

Background In the photodynamic therapy (PDT) of non‐aggressive basal cell carcinomas (BCCs), 5‐aminolevulinic acid nanoemulsion (BF‐200ALA) has shown non‐inferior efficacy when compared with methyl aminolevulinate (MAL), a widely used photosensitizer. Hexyl aminolevulinate (HAL) is an interesting alternative photosensitizer. To our knowledge, this is the first study using HAL‐PDT in the treatment of BCCs. Objectives To compare the histological clearance, tolerability (pain and post‐treatment reaction), and cosmetic outcome of MAL, BF‐200 ALA, and low‐concentration HAL in the PDT of non‐aggressive BCCs. Methods Ninety‐eight histologically verified non‐aggressive BCCs met the inclusion criter…

Skin Neoplasmsmedicine.medical_treatmentPhotodynamic therapyGastroenterologylaw.invention030207 dermatology & venereal diseases0302 clinical medicineMethyl aminolevulinateRandomized controlled trialnon-aggressive basal cell carcinomalawTOPICAL IMIQUIMODProspective Studies10. No inequalityProspective cohort studyPhotosensitizing AgentsSisätaudit - Internal medicinePAINkarsinoomat3. Good healthTreatment OutcomeInfectious Diseasesphotodynamic therapyTolerabilityFluorouracil030220 oncology & carcinogenesisBOWENS-DISEASEmedicine.symptommedicine.drugmedicine.medical_specialtyBiolääketieteet - Biomedicine3122 Cancersmethyl aminolevulinateEUROPEAN GUIDELINESDermatologySINGLE-BLINDLesion03 medical and health scienceshexyl aminolevulinatenon‐aggressive basal cell carcinomaSyöpätaudit - CancersInternal medicineparasitic diseasesMANAGEMENTmedicineCarcinomaHumansANESTHESIAbusiness.industryAminolevulinic Acidmedicine.disease5‐aminolevulinic acid nanoemulsionFLUOROURACILPROTOPORPHYRIN IX FORMATIONfotodynaaminen hoitoPhotochemotherapyCarcinoma Basal Cell5-aminolevulinic acid nanoemulsionbusinessSKINJournal of the European Academy of Dermatology and Venereology
researchProduct

Fluorescein for resection of high-grade gliomas: A safety study control in a single center and review of the literature

2017

Background: The importance of a complete resection of high-grade gliomas (HGGs) has been highlighted in scientific literature, in order to limit tumor recurrence and above all to improve disease-free survival rates. Several fluorescent biomarkers have been tested to improve intraoperative identification of residual tumor; 5-aminolevulinic acid (5-ALA) and fluorescein sodium (FS) are now starting to play a central role in glioma surgery. We performed a retrospective analysis on 47 patients operated for HGGs. Here we report our preliminary data. Methods: Data of 47 consecutive patients with HGG have been collected in our study (25 males, 22 females; mean age: 60.3 years, range: 27-86 years). …

medicine.medical_specialtySingle CenterResection03 medical and health scienceschemistry.chemical_compound0302 clinical medicineGliomaYELLOW 560 filterMedicinefluorescein sodiumFluoresceinAdverse effectSettore MED/27 - Neurochirurgiabusiness.industrySubtotal ResectionPartial resectionmedicine.diseaseextent of resectionSurgerychemistry5-aminolevulinic acid030220 oncology & carcinogenesisSurgeryNeuro-Oncology: Original ArticleNeurology (clinical)Sodium fluoresceinbusinessNuclear medicinehigh-grade gliomas030217 neurology & neurosurgerySurgical Neurology International
researchProduct